| pubmed-article:2461793 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2461793 | lifeskim:mentions | umls-concept:C0001489 | lld:lifeskim |
| pubmed-article:2461793 | lifeskim:mentions | umls-concept:C1257890 | lld:lifeskim |
| pubmed-article:2461793 | lifeskim:mentions | umls-concept:C0441833 | lld:lifeskim |
| pubmed-article:2461793 | lifeskim:mentions | umls-concept:C0003250 | lld:lifeskim |
| pubmed-article:2461793 | lifeskim:mentions | umls-concept:C1999270 | lld:lifeskim |
| pubmed-article:2461793 | lifeskim:mentions | umls-concept:C1880022 | lld:lifeskim |
| pubmed-article:2461793 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:2461793 | pubmed:dateCreated | 1989-1-26 | lld:pubmed |
| pubmed-article:2461793 | pubmed:abstractText | The interaction between a panel of ten monoclonal antibodies and hemorrhagic enteritis virus, a group II avian adenovirus, was determined. The monoclonal antibodies reacted with all nine isolates of group II avian adenoviruses, but not with any of five types of group I avian adenoviruses. All ten monoclonal antibodies recognized antigenic determinants on the hexon protein of hemorrhagic enteritis virus when analyzed by immunoprecipitation and immunoblotting. They reacted only with the native hexon protein and not with protein denatured by sodium dodecyl sulfate or guanidine-HCl/urea treatment combined with reduction and carboxymethylation. Based on the results of competitive binding assays, the panel of monoclonal antibodies could be subdivided into two groups, which recognized different antigenic domains of the hemorrhagic enteritis virus hexon protein. The monoclonal antibodies in group 1 neutralized hemorrhagic enteritis virus infectivity while the monoclonal antibodies of group 2 did not. Group 1 consisted of eight monoclonal antibodies which could be further subdivided into subgroups 1A, 1B, 1C and 1D. The subdivision of the monoclonal antibodies was based on the degree of blocking in the competitive binding assays and differences in their ability to induce enhancement. In general, the monoclonal antibodies had a higher avidity for the virulent isolate of hemorrhagic enteritis virus than for the avirulent hemorrhagic enteritis virus isolate. | lld:pubmed |
| pubmed-article:2461793 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461793 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461793 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461793 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461793 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461793 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461793 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461793 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461793 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461793 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461793 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461793 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461793 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461793 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461793 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461793 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461793 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461793 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461793 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461793 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461793 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461793 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461793 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461793 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461793 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461793 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461793 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461793 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461793 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461793 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461793 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461793 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461793 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461793 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461793 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461793 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461793 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461793 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461793 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461793 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461793 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461793 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461793 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461793 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461793 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2461793 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461793 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2461793 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461793 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461793 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461793 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2461793 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:2461793 | pubmed:issn | 0830-9000 | lld:pubmed |
| pubmed-article:2461793 | pubmed:author | pubmed-author:van den... | lld:pubmed |
| pubmed-article:2461793 | pubmed:author | pubmed-author:van Drunen... | lld:pubmed |
| pubmed-article:2461793 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2461793 | pubmed:volume | 52 | lld:pubmed |
| pubmed-article:2461793 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2461793 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2461793 | pubmed:pagination | 458-67 | lld:pubmed |
| pubmed-article:2461793 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
| pubmed-article:2461793 | pubmed:meshHeading | pubmed-meshheading:2461793-... | lld:pubmed |
| pubmed-article:2461793 | pubmed:meshHeading | pubmed-meshheading:2461793-... | lld:pubmed |
| pubmed-article:2461793 | pubmed:meshHeading | pubmed-meshheading:2461793-... | lld:pubmed |
| pubmed-article:2461793 | pubmed:meshHeading | pubmed-meshheading:2461793-... | lld:pubmed |
| pubmed-article:2461793 | pubmed:meshHeading | pubmed-meshheading:2461793-... | lld:pubmed |
| pubmed-article:2461793 | pubmed:meshHeading | pubmed-meshheading:2461793-... | lld:pubmed |
| pubmed-article:2461793 | pubmed:meshHeading | pubmed-meshheading:2461793-... | lld:pubmed |
| pubmed-article:2461793 | pubmed:meshHeading | pubmed-meshheading:2461793-... | lld:pubmed |
| pubmed-article:2461793 | pubmed:meshHeading | pubmed-meshheading:2461793-... | lld:pubmed |
| pubmed-article:2461793 | pubmed:meshHeading | pubmed-meshheading:2461793-... | lld:pubmed |
| pubmed-article:2461793 | pubmed:meshHeading | pubmed-meshheading:2461793-... | lld:pubmed |
| pubmed-article:2461793 | pubmed:year | 1988 | lld:pubmed |
| pubmed-article:2461793 | pubmed:articleTitle | Characterization of group II avian adenoviruses with a panel of monoclonal antibodies. | lld:pubmed |
| pubmed-article:2461793 | pubmed:affiliation | Veterinary Infectious Disease Organization (VIDO), University of Saskatchewan, Saskatoon. | lld:pubmed |
| pubmed-article:2461793 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2461793 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
